These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34824144)

  • 21. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.
    Adhikari A; Subedi RC; Acharya S; Paudel R
    JNMA J Nepal Med Assoc; 2020 Jul; 58(227):487-490. PubMed ID: 32827010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series.
    Yang X; Li AN; Zhao XH; Liu XW; Wang SJ
    Int J Neurosci; 2019 Aug; 129(8):754-761. PubMed ID: 30621547
    [No Abstract]   [Full Text] [Related]  

  • 24. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
    Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
    Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
    Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
    J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmune parkinsonism with faciobrachiocrural dystonic seizures: a new phenotype of leucine-rich glioma-inactivated 1 (LGI1) autoimmunity.
    Sasikumar S; Vincent J; Gopinath S; Nambiar V; Umesh SU; Kannoth S; Antony D; Mathai A; Anandakuttan A
    Acta Neurol Belg; 2022 Oct; 122(5):1323-1328. PubMed ID: 35851655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
    Irani SR; Michell AW; Lang B; Pettingill P; Waters P; Johnson MR; Schott JM; Armstrong RJ; S Zagami A; Bleasel A; Somerville ER; Smith SM; Vincent A
    Ann Neurol; 2011 May; 69(5):892-900. PubMed ID: 21416487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
    Ludewig S; Salzburger L; Goihl A; Rohne J; Leypoldt F; Bittner D; Düzel E; Schraven B; Reinhold D; Korte M; Körtvélyessy P
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
    Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
    JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review.
    Li X; Yuan J; Liu L; Hu W
    BMC Neurol; 2019 Feb; 19(1):19. PubMed ID: 30732585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.
    Ariño H; Armangué T; Petit-Pedrol M; Sabater L; Martinez-Hernandez E; Hara M; Lancaster E; Saiz A; Dalmau J; Graus F
    Neurology; 2016 Aug; 87(8):759-65. PubMed ID: 27466467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification.
    Liang M; Niu N; Jia C; Fan S; Liu L; Cui R; Guan H
    Clin Nucl Med; 2023 Nov; 48(11):e516-e522. PubMed ID: 37703438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limbic encephalitis with LGI1 antibodies in a 14-year-old boy.
    Schimmel M; Frühwald MC; Bien CG
    Eur J Paediatr Neurol; 2018 Jan; 22(1):190-193. PubMed ID: 28919330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Limbic Encephalitis With New-Onset Panic Attacks.
    Coleman B; Sawhney K; LaPenna P
    Cureus; 2024 Apr; 16(4):e58406. PubMed ID: 38756253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis.
    Meier L; Weinrebe W; Annoni JM; Petersen JA
    Clin Interv Aging; 2022; 17():1423-1432. PubMed ID: 36187571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.
    Li G; Liu X; Wang M; Yu T; Ren J; Wang Q
    Acta Neurol Scand; 2022 Aug; 146(2):137-143. PubMed ID: 35373330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morvan syndrome associated with LGI1 antibody: a case report.
    Zhang SJ; Xue YY; Yu H; Tao QQ
    BMC Neurol; 2021 May; 21(1):185. PubMed ID: 33941099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Treatment and Follow-Up of Anti-LGI1 Limbic Encephalitis.
    Yu J; Yu X; Fang S; Zhang Y; Lin W
    Eur Neurol; 2016; 75(1-2):5-11. PubMed ID: 26694143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.